scispace - formally typeset
Y

Yongjun Wang

Researcher at Scripps Research Institute

Publications -  38
Citations -  4642

Yongjun Wang is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Nuclear receptor & Receptor. The author has an hindex of 26, co-authored 38 publications receiving 4128 citations. Previous affiliations of Yongjun Wang include Chinese Academy of Sciences & Nanjing Agricultural University.

Papers
More filters
Journal ArticleDOI

Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA.

TL;DR: Structures of intact PPAR-γ and RXR-α are presented as a heterodimer bound to DNA, ligands and coactivator peptides, allowing the ligand-binding domain (LBD) of PPar-γ to contact multiple domains in both proteins.
Journal ArticleDOI

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

TL;DR: Treatment of diet-induced obese mice with a REV-ERB agonist decreased obesity by reducing fat mass and markedly improving dyslipidaemia and hyperglycaemia, indicating that synthetic REV -ERB ligands that pharmacologically target the circadian rhythm may be beneficial in the treatment of sleep disorders as well as metabolic diseases.
Journal ArticleDOI

Suppression of TH17 Differentiation and Autoimmunity by a Synthetic ROR Ligand

TL;DR: The data demonstrate the feasibility of targeting the orphan receptors RORα and RORγt to inhibit specifically TH17 cell differentiation and function, and indicate that this novel class of compound has potential utility in the treatment of autoimmune diseases.
Journal ArticleDOI

QTL mapping of ten agronomic traits on the soybean ( Glycine max L. Merr.) genetic map and their association with EST markers.

TL;DR: A set of 184 recombinant inbred lines (RILs) derived from soybean vars was used to construct a genetic linkage map, and the two parents exhibit contrasting characteristics for most of the traits that were mapped.
Journal ArticleDOI

The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor-α/γ Inverse Agonist

TL;DR: The results demonstrate that small molecules can be used to target the RORs for therapeutic intervention in metabolic and immune disorders and an excellent starting point for the development of ROR selective modulators.